Related references
Note: Only part of the references are listed.Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis
Tomohiro Sekiguchi et al.
PLOS ONE (2015)
Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement
Ki Tae Suk et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Predictors of quality of life in patients evaluated for liver transplantation
Maximilian Jara et al.
CLINICAL TRANSPLANTATION (2014)
Soluble intracellular adhesion molecule, M30 and M65 as serum markers of disease activity and prognosis in cholestatic liver diseases
Gerald Denk et al.
HEPATOLOGY RESEARCH (2014)
Use of Non-Invasive Parameters of Non-Alcoholic Steatohepatitis and Liver Fibrosis in Daily Practice - An Exploratory Case-Control Study
Karel Dvorak et al.
PLOS ONE (2014)
Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis
Diana Joka et al.
HEPATOLOGY (2012)
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
Naim Alkhouri et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Quality of life in cirrhosis is related to potentially treatable factors
Inigo Les et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Predictors of health-related quality of life in patients with chronic liver disease
A. Afendy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Quality of Life in Adults with Nonalcoholic Fatty Liver Disease: Baseline Data from the Nonalcoholic Steatohepatitis Clinical Research Network
Kristin David et al.
HEPATOLOGY (2009)
Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis: A Multicenter Validation Study
Ariel E. Feldstein et al.
HEPATOLOGY (2009)
Impact of obesity and type 2 diabetes on health-related quality of life in the general population in England
Stephen C. L. Gough et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2009)
The factorial structure of the Chronic Liver Disease Questionnaire (CLDQ)
Karl-Heinz Schulz et al.
QUALITY OF LIFE RESEARCH (2008)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis
Yusuf Yilmaz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation
E. Yagmur et al.
CLINICAL BIOCHEMISTRY (2007)
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C
B Kronenberger et al.
JOURNAL OF VIRAL HEPATITIS (2005)
MELD fails to measure quality of life in liver transplant candidates
S Saab et al.
LIVER TRANSPLANTATION (2005)
Determinants of Health-Related Quality of Life in Patients With Chronic Liver Diseases
Winfried Haeuser et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Quality of life and cognitive function in hepatitis C at different stages of liver disease
J Córdoba et al.
JOURNAL OF HEPATOLOGY (2003)
Factors associated with poor health-related quality of life of patients with cirrhosis
G Marchesini et al.
GASTROENTEROLOGY (2001)
Share Paper
